tetano
Editor, Senior Moderator
Neurol Clin Pract
. 2021 Apr;11(2):e135-e146.
doi: 10.1212/CPJ.0000000000000897.
Potential Neurologic Manifestations of COVID-19
Anna S Nordvig[SUP] 1 [/SUP], Kathryn T Fong[SUP] 1 [/SUP], Joshua Z Willey[SUP] 1 [/SUP], Kiran T Thakur[SUP] 1 [/SUP], Amelia K Boehme[SUP] 1 [/SUP], Wendy S Vargas[SUP] 1 [/SUP], Craig J Smith[SUP] 1 [/SUP], Mitchell S V Elkind[SUP] 1 [/SUP]
Affiliations
Abstract
Purpose of review: Neurologic complications are increasingly recognized in the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This coronavirus is related to severe acute respiratory syndrome coronavirus (SARS-CoV) and other human coronavirus-related illnesses that are associated with neurologic symptoms. These symptoms raise the question of a neuroinvasive potential of SARS-CoV-2.
Recent findings: Potential neurologic symptoms and syndromes of SARS-CoV-2 include headache, fatigue, dizziness, anosmia, ageusia, anorexia, myalgias, meningoencephalitis, hemorrhage, altered consciousness, Guillain-Barr? syndrome, syncope, seizure, and stroke. In addition, we discuss neurologic effects of other coronaviruses, special considerations for management of neurologic patients, and possible long-term neurologic and public health sequelae.
Summary: As SARS-CoV-2 is projected to infect a large part of the world's population, understanding the potential neurologic implications of COVID-19 will help neurologists and others recognize and intervene in neurologic morbidity during and after the pandemic of 2020.
. 2021 Apr;11(2):e135-e146.
doi: 10.1212/CPJ.0000000000000897.
Potential Neurologic Manifestations of COVID-19
Anna S Nordvig[SUP] 1 [/SUP], Kathryn T Fong[SUP] 1 [/SUP], Joshua Z Willey[SUP] 1 [/SUP], Kiran T Thakur[SUP] 1 [/SUP], Amelia K Boehme[SUP] 1 [/SUP], Wendy S Vargas[SUP] 1 [/SUP], Craig J Smith[SUP] 1 [/SUP], Mitchell S V Elkind[SUP] 1 [/SUP]
Affiliations
- PMID: 33842082
- PMCID: PMC8032406 (available on 2022-04-01)
- DOI: 10.1212/CPJ.0000000000000897
Abstract
Purpose of review: Neurologic complications are increasingly recognized in the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This coronavirus is related to severe acute respiratory syndrome coronavirus (SARS-CoV) and other human coronavirus-related illnesses that are associated with neurologic symptoms. These symptoms raise the question of a neuroinvasive potential of SARS-CoV-2.
Recent findings: Potential neurologic symptoms and syndromes of SARS-CoV-2 include headache, fatigue, dizziness, anosmia, ageusia, anorexia, myalgias, meningoencephalitis, hemorrhage, altered consciousness, Guillain-Barr? syndrome, syncope, seizure, and stroke. In addition, we discuss neurologic effects of other coronaviruses, special considerations for management of neurologic patients, and possible long-term neurologic and public health sequelae.
Summary: As SARS-CoV-2 is projected to infect a large part of the world's population, understanding the potential neurologic implications of COVID-19 will help neurologists and others recognize and intervene in neurologic morbidity during and after the pandemic of 2020.